3-Phenylpropanoylfentanyl

From Wikipedia, the free encyclopedia

Legal status
3-Phenylpropanoylfentanyl
Legal status
Legal status
Identifiers
  • N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-3-phenylpropanamide
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC28H32N2O
Molar mass412.577 g·mol−1
3D model (JSmol)
  • c2ccccc2CCN1CCC(CC1)N(c3ccccc3)C(=O)CCc4ccccc4
  • InChI=1S/C28H32N2O/c31-28(17-16-24-10-4-1-5-11-24)30(26-14-8-3-9-15-26)27-19-22-29(23-20-27)21-18-25-12-6-2-7-13-25/h1-15,27H,16-23H2
  • Key:DIRAGWDYMRIDIO-UHFFFAOYSA-N

3-Phenylpropanoylfentanyl (β'-phenylfentanyl) is an opioid analgesic that is an analog of fentanyl, which was invented in 1981,[2] and has been sold as a designer drug, first identified in March 2017 in Sweden.[3]

Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.[4] A new wave of fentanyl analogues and associated deaths began in around 2014 in the US, and have continued to grow in prevalence. Since 2016 these drugs have been responsible for hundreds of overdose deaths every week.[5]

See also

References

Related Articles

Wikiwand AI